Isao Murakami

2.1k citations

36 papers · 1.4k indexed · 1 hit paper · h-index 15

Epidemiology top 5%
Oncology top 5%
Molecular Biology
Pulmonary and Respiratory Medicine top 5%
Cancer Research top 10%

Co-authors: John Doorbar Heather Griffin Nagayasu Egawa Christian Kranjec Kenichi Suda Tetsuya Mitsudomi Kenji Tomizawa Yasushi Yatabe
Topics: Lung Cancer Treatments and Mutations (15 papers)Lung Cancer Research Studies (8 papers)Cervical Cancer and HPV Research (7 papers)
Cited by: Oncology Cancer Research Epidemiology
Journals: Journal of Clinical Oncology American Journal of Respiratory and Critical Care Medicine Cancer Research
Partner nations: Japan United States United Kingdom

In The Last Decade

Isao Murakami

35 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human papillomavirus molecular biology and disease association

2015 624 citations John Doorbar, Nagayasu Egawa et al. profile →

Peers

Countries citing papers authored by Isao Murakami

Since Specialization

Citations

This map shows the geographic impact of Isao Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Murakami more than expected).

Fields of papers citing papers by Isao Murakami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Murakami. The network helps show where Isao Murakami may publish in the future.

Co-authorship network of co-authors of Isao Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Murakami. A scholar is included among the top collaborators of Isao Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Murakami. Isao Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review 2023 ·Journal of Gynecologic Oncology ·Isao Murakami,Hiroko Machida,Tohru Morisada,Yasuhisa Terao,Tsutomu Tabata,Mikio Mikami,Yasuyuki Hirashima,Yoichi Kobayashi,Tsukasa Baba,Satoru Nagase	9
2	Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic Carcinomas 2021 ·Clinical Lung Cancer ·Toshio Fujino,Kenichi Suda,Kazuko Sakai,Isao Murakami,Shigeki Shimizu,Shuta Ohara,T. Koga,Akira Hamada,Junichi Soh,Kazuto Nishio,Tetsuya Mitsudomi	1
3	Spatial heterogeneity of acquired resistance mechanisms to 1st/2nd generation EGFR tyrosine kinase inhibitors in lung cancer 2020 ·Lung Cancer ·Kenichi Suda,Isao Murakami,Keiko Obata,Kazuko Sakai,Toshio Fujino,T. Koga,Shuta Ohara,Akira Hamada,Junichi Soh,Kazuto Nishio,Tetsuya Mitsudomi	6
4	Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance 2019 ·PLoS Pathogens ·Isao Murakami,Nagayasu Egawa,Heather Griffin,Wen Yin,Christian Kranjec,Tomomi Nakahara,Tohru Kiyono,John Doorbar	27
5	CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer 2018 ·Molecular Cancer Therapeutics ·Kenichi Suda,Isao Murakami,Hui Yu,Jihye Kim,Aik Choon Tan,Hiroshi Mizuuchi,Leslie Rozeboom,Kim Ellison,Christopher J. Rivard,Tetsuya Mitsudomi,Fred R. Hirsch	39
6	Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions 2018 ·Journal of Thoracic Oncology ·Kenichi Suda,Jihye Kim,Isao Murakami,Leslie Rozeboom,Masaki Shimoji,Shigeki Shimizu,Christopher J. Rivard,Tetsuya Mitsudomi,Aik Choon Tan,Fred R. Hirsch	21
7	Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis 2018 ·Lung Cancer ·Hibiki Udagawa,Shigeki Umemura,Isao Murakami,Sachiyo Mimaki,Hideki Makinoshima,Genichiro Ishii,Tomohiro Miyoshi,Keisuke Kirita,Shingo Matsumoto,Kiyotaka Yoh,Seiji Niho,Katsuya Tsuchihara,Kōichi Goto	16
8	HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions 2017 ·PLoS Pathogens ·Nagayasu Egawa,Qian Wang,Heather Griffin,Isao Murakami,Deborah Jackson,Radma Mahmood,John Doorbar	38
9	Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation 2017 ·Journal of Thoracic Oncology ·Kenichi Suda,Isao Murakami,Hui Yu,Jihye Kim,Kim Ellison,Christopher J. Rivard,Tetsuya Mitsudomi,Fred R. Hirsch	19
10	Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation 2016 ·Journal of Thoracic Oncology ·Kenichi Suda,Isao Murakami,Hui Yu,Kim Ellison,Masaki Shimoji,Carlo Genova,Christopher J. Rivard,Tetsuya Mitsudomi,Fred R. Hirsch	12
11	Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer 2015 ·Lung Cancer ·Kenichi Suda,Isao Murakami,Kazuko Sakai,Kenji Tomizawa,Hiroshi Mizuuchi,Katsuaki Sato,Kazuto Nishio,Tetsuya Mitsudomi	30
12	Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer 2015 ·Scientific Reports ·Kenichi Suda,Isao Murakami,Kazuko Sakai,Hiroshi Mizuuchi,Shigeki Shimizu,Katsuaki Sato,Kenji Tomizawa,Shuta Tomida,Yasushi Yatabe,Kazuto Nishio,Tetsuya Mitsudomi	74
13	Association of EPAS1 Gene rs4953354 Polymorphism with Susceptibility to Lung Adenocarcinoma in Female Japanese Non-Smokers 2014 ·Journal of Thoracic Oncology ·Shinichi Iwamoto,Keiji Tanimoto,(unknown),(unknown),(unknown),(unknown),Akihisa Sutani,Takashige Kuraki,Keiko Hiyama,Isao Murakami,Hidetaka Eguchi,Takeshi Isobe	13
14	Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia 2013 ·Journal of Clinical Virology ·Isao Murakami,Takuma Fujii,Katsuaki Dan,Miyuki Saito,Akiko Ohno,Takashi Iwata,Daisuke Aoki	12
15	Tumor volume and lymphovascular space invasion as a prognostic factor in early invasive adenocarcinoma of the cervix 2012 ·Journal of Gynecologic Oncology ·Isao Murakami,Takuma Fujii,Kaori Kameyama,Takashi Iwata,Miyuki Saito,Kaneyuki Kubushiro,Daisuke Aoki	12
16	Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer 2010 ·Clinical Cancer Research ·Kenichi Suda,Isao Murakami,Tatsuya Katayama,Kenji Tomizawa,Hirotaka Osada,Yoshitaka Sekido,Yoshihiko Maehara,Yasushi Yatabe,Tetsuya Mitsudomi	170
17	An Adeno-Associated Virus Vector Efficiently and Specifically Transduces Mouse Skeletal Muscle 2010 ·Molecular Biotechnology ·Isao Murakami,Takamasa Takeuchi,Mayuyo Mori‐Uchino,Seiichiro Mori,Takuma Fujii,Daisuke Aoki,Keiichi Nakagawa,Tadahito Kanda	4
18	Virtual bronchoscopy aids management of lung cancer 2007 ·Respirology ·Seiji Okimasa,Satoshi Shibata,(unknown),(unknown),Isao Murakami,Eriko Shigeto	3
19	Detection of P53 Gene Mutations in Cytopathology and Biopsy Specimens From Patients With Lung Cancer 1996 ·American Journal of Respiratory and Critical Care Medicine ·Isao Murakami,Yasuhiro Fujiwara,(unknown),Keiko Hiyama,(unknown),(unknown)	17
20	A Clinicopathological Study of Adenosquamous Carcinoma of the Lung. 1992 ·Haigan ·Yasuhiro Yoshida,Kouki Inai,Takashi Nishisaka,Yukio Takeshima,Shuji Yonehara,Isao Murakami,(unknown),(unknown),Kenji Hasegawa,Michio Yamakido	2

About Isao Murakami

Isao Murakami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Obstetrics and Gynecology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (8 papers) and Cervical Cancer and HPV Research (7 papers). The work is most often cited by research in Oncology (486 citations), Cancer Research (251 citations) and Epidemiology (572 citations). Isao Murakami has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include John Doorbar, Heather Griffin, Nagayasu Egawa, Christian Kranjec, Kenichi Suda, Tetsuya Mitsudomi, Kenji Tomizawa, Yasushi Yatabe, Yoshitaka Sekido and Yoshihiko Maehara. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact